Skip to main content

Transgenomic Opening PGx Services Lab in China

NEW YORK (GenomeWeb News) – Transgenomic said today it has entered into a laboratory services partnership agreement with the Guangzhou Family Planning Center in China that it will use to provide pharmacogenomic analysis services to pharmaceutical companies seeking to perform clinical trials in China.
 
Transgenomic said it has already equipped the Guangzhou facility with the technology necessary to provide pharmacogenomics services.
 
Transgenomic President and CEO Craig Tuttle said the agreement provides the firm with the lab it needs to open “significant new clinical testing opportunities for us.”
 

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.